Bright Minds Biosciences Inc. (DRUG)
NASDAQ·Healthcare·Biotechnology
$71.13
-1.15%
Mkt Cap $553.32M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (5 analysts)
$136.50
Range $126.00 – $147.00
Implied Upside
+91.9%
Consensus $136.50 vs current $71.13